Accrued Expenses and Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

	December 31,
	2023		2022
	(in thousands)
Vaxcyte-related accrual under Vaxcyte Supply Agreement	$	6,933	$	4,830
CMO-related accrual		8,195		3,900
Clinical trials-related accrual		4,283		2,954
Tax and related expenses		15,165		-
Other		3,897		3,080
Total accrued expenses and other current liabilities	$	38,473	$	14,764